Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used for the treatment of hepatitis C.[1] It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir, daclatasvir, or velpatasvir.[3][4] Cure rates are 30 to 97% depending on the type of hepatitis C virus involved.[5] Safety during pregnancy is unclear; while, some of the medications used in combination may result in harm to the baby.[5] ItContinue reading “Sovaldi , for Hepatitis C, is $483 in India and $84,000 in the USA”
Tag Archives: Hepatitis C
The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination
CDC Grand Rounds: Addressing Health Disparities in Early Childhood Lara R. Robinson, PhD; Rebecca H. Bitsko, PhD; Ross A. Thompson, PhD; et al. Early childhood represents a period of growth that lays the foundation for successful learning, development, and health. The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia,Continue reading “The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination”
Hepatitis C Virus Infection in African Americans
By Brian Pearlman Hepatitis C is more prevalent among African Americans than among persons of any other racial group in the United States. However, comparatively little data are available on the natural history and treatment of hepatitis C in this population. Compared with white persons, African American persons have a lower rate of viral clearanceContinue reading “Hepatitis C Virus Infection in African Americans”
Does DAA Therapy Up Risk for Liver Cancer? It’s Debatable
By Merin Varghese, MD Is there an increased risk of hepatocellular carcinoma after treatment of hepatitis C? A short review of studies presented at the International Liver Congress 2017 may help answer the question. Direct acting antiviral (DAA) therapy for hepatitis C (HCV) has revolutionized treatment by improving patient outcomes with fewer side effectsContinue reading “Does DAA Therapy Up Risk for Liver Cancer? It’s Debatable”
What is hepatitis C?
What is hepatitis C? by Connie b. Dellobuono Answer by Connie b. Dellobuono: Out of some 2,750 drugs covered by Medicare’s Part D benefit, two pills for hepatitis C infection – Harvoni and Sovaldi – accounted for nearly $7.5 billion in catastrophic drug costs in 2015. The most common problem due to hepatitis C butContinue reading “What is hepatitis C?”